Wells Fargo
ROSG

Wells Fargo’s Rosetta Genomics Ltd. ROSG Stock Holding History

Wells Fargo’s Portfolio ROSG Stock Details ROSG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-167
Closed – – 6847
2018
Q1 		$0 Hold
167
– – ﹤0.01% 6792
2017
Q4 		$0 Hold
167
– – ﹤0.01% 6772
2017
Q3 		$0 Hold
167
– – ﹤0.01% 6694
2017
Q2 		$0 Hold
167
– – ﹤0.01% 6718
2017
Q1 		$0 Hold
167
– – ﹤0.01% 6709
2016
Q4 		$1K Hold
167
– – ﹤0.01% 6216
2016
Q3 		$2K Hold
167
– – ﹤0.01% 6076
2016
Q2 		$2K Buy
167
+84
+101% +$1.2K ﹤0.01% 5976
2016
Q1 		$1K Hold
83
– – ﹤0.01% 6147
2015
Q4 		$1K Hold
83
– – ﹤0.01% 6155
2015
Q3 		$2K Hold
83
– – ﹤0.01% 6022
2015
Q2 		$3K Sell
83
-84
-50% -$3.59K ﹤0.01% 6132
2015
Q1 		$6K Sell
167
-132
-44% -$5K ﹤0.01% 5796
2014
Q4 		$8K Sell
299
-11,177
-97% -$363K ﹤0.01% 5740
2014
Q3 		$483K Sell
11,476
-1,368
-11% -$62.2K ﹤0.01% 3920
2014
Q2 		$664K Buy
12,844
+12,336
+2,428% +$611K ﹤0.01% 3779
2014
Q1 		$30K Buy
+508
New +$26.2K ﹤0.01% 5101

Other funds holding ROSG

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Wells Fargo's ROSG Position: Q2 2018 in Review

Wells Fargo sold out of Rosetta Genomics Ltd. (ROSG) in Q2 2018, closing a stake of 167 shares.

Wells Fargo first reported a position in ROSG in Q1 2014 and held it in 17 quarters. The position peaked at $664K in Q2 2014. 2 funds tracked by Wall St. Rank hold ROSG as of Q2 2018.

  • Wells Fargo reported no remaining Rosetta Genomics Ltd. position as of Q2 2018 after selling out during the quarter.
  • Wells Fargo sold 167 Rosetta Genomics Ltd. shares in Q2 2018.
  • Wells Fargo first reported a position in Rosetta Genomics Ltd. in Q1 2014 and held it in 17 quarters.
  • Wells Fargo's Rosetta Genomics Ltd. position peaked at $664K in Q2 2014.
  • 2 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q2 2018.

Based on Wells Fargo's 13F filing for Q2 2018, filed 1 Aug 2018.